Cargando…
Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model
OBJECTIVE: Pituitary adenylate cyclase–activating polypeptide (PACAP) expressed in capsaicin-sensitive sensory neurons and immune cells has divergent functions in inflammatory and pain processes. This study was undertaken to investigate the involvement of PACAP in a mouse model of rheumatoid arthrit...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320777/ https://www.ncbi.nlm.nih.gov/pubmed/25048575 http://dx.doi.org/10.1002/art.38772 |
_version_ | 1782356182597369856 |
---|---|
author | Botz, Bálint Bölcskei, Kata Kereskai, László Kovács, Miklós Németh, Tamás Szigeti, Krisztián Horváth, Ildikó Máthé, Domokos Kovács, Noémi Hashimoto, Hitoshi Reglődi, Dóra Szolcsányi, János Pintér, Erika Mócsai, Attila Helyes, Zsuzsanna |
author_facet | Botz, Bálint Bölcskei, Kata Kereskai, László Kovács, Miklós Németh, Tamás Szigeti, Krisztián Horváth, Ildikó Máthé, Domokos Kovács, Noémi Hashimoto, Hitoshi Reglődi, Dóra Szolcsányi, János Pintér, Erika Mócsai, Attila Helyes, Zsuzsanna |
author_sort | Botz, Bálint |
collection | PubMed |
description | OBJECTIVE: Pituitary adenylate cyclase–activating polypeptide (PACAP) expressed in capsaicin-sensitive sensory neurons and immune cells has divergent functions in inflammatory and pain processes. This study was undertaken to investigate the involvement of PACAP in a mouse model of rheumatoid arthritis. METHODS: Arthritis was induced in PACAP(−/−) and wild-type (PACAP(+/+)) mice by K/BxN serum transfer. General features of the disease were investigated by semiquantitative scoring, plethysmometry, and histopathologic analysis. Mechano- and thermonociceptive thresholds and motor functions were also evaluated. Metabolic activity was assessed by positron emission tomography. Bone morphology was measured by in vivo micro–computed tomography, myeloperoxidase activity and superoxide production by bioluminescence imaging with luminol and lucigenin, respectively, and vascular permeability by fluorescent indocyanine green dye study. RESULTS: PACAP(+/+) mice developed notable joint swelling, reduced grasping ability, and mechanical (but not thermal) hyperalgesia after K/BxN serum transfer. In PACAP(−/−) mice clinical scores and edema were significantly reduced, and mechanical hyperalgesia and motor impairment were absent, throughout the 2-week period of observation. Metabolic activity and superoxide production increased in the tibiotarsal joints of wild-type mice but were significantly lower in PACAP(−/−) animals. Myeloperoxidase activity in the ankle joints of PACAP(−/−) mice was significantly reduced in the early phase of arthritis, but increased in the late phase. Synovial hyperplasia was also significantly increased, and progressive bone spur formation was observed in PACAP-deficient mice only. CONCLUSION: In PACAP-deficient mice with serum-transfer arthritis, joint swelling, vascular leakage, hyperalgesia, and early inflammatory cell accumulation are reduced; in the later phase of the disease, immune cell function and bone neoformation are increased. Elucidation of the underlying pathways of PACAP activity may open promising new avenues for development of therapy in inflammatory arthritis. |
format | Online Article Text |
id | pubmed-4320777 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BlackWell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-43207772015-02-13 Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model Botz, Bálint Bölcskei, Kata Kereskai, László Kovács, Miklós Németh, Tamás Szigeti, Krisztián Horváth, Ildikó Máthé, Domokos Kovács, Noémi Hashimoto, Hitoshi Reglődi, Dóra Szolcsányi, János Pintér, Erika Mócsai, Attila Helyes, Zsuzsanna Arthritis Rheumatol Experimental Arthritis OBJECTIVE: Pituitary adenylate cyclase–activating polypeptide (PACAP) expressed in capsaicin-sensitive sensory neurons and immune cells has divergent functions in inflammatory and pain processes. This study was undertaken to investigate the involvement of PACAP in a mouse model of rheumatoid arthritis. METHODS: Arthritis was induced in PACAP(−/−) and wild-type (PACAP(+/+)) mice by K/BxN serum transfer. General features of the disease were investigated by semiquantitative scoring, plethysmometry, and histopathologic analysis. Mechano- and thermonociceptive thresholds and motor functions were also evaluated. Metabolic activity was assessed by positron emission tomography. Bone morphology was measured by in vivo micro–computed tomography, myeloperoxidase activity and superoxide production by bioluminescence imaging with luminol and lucigenin, respectively, and vascular permeability by fluorescent indocyanine green dye study. RESULTS: PACAP(+/+) mice developed notable joint swelling, reduced grasping ability, and mechanical (but not thermal) hyperalgesia after K/BxN serum transfer. In PACAP(−/−) mice clinical scores and edema were significantly reduced, and mechanical hyperalgesia and motor impairment were absent, throughout the 2-week period of observation. Metabolic activity and superoxide production increased in the tibiotarsal joints of wild-type mice but were significantly lower in PACAP(−/−) animals. Myeloperoxidase activity in the ankle joints of PACAP(−/−) mice was significantly reduced in the early phase of arthritis, but increased in the late phase. Synovial hyperplasia was also significantly increased, and progressive bone spur formation was observed in PACAP-deficient mice only. CONCLUSION: In PACAP-deficient mice with serum-transfer arthritis, joint swelling, vascular leakage, hyperalgesia, and early inflammatory cell accumulation are reduced; in the later phase of the disease, immune cell function and bone neoformation are increased. Elucidation of the underlying pathways of PACAP activity may open promising new avenues for development of therapy in inflammatory arthritis. BlackWell Publishing Ltd 2014-10 2014-09-26 /pmc/articles/PMC4320777/ /pubmed/25048575 http://dx.doi.org/10.1002/art.38772 Text en © 2014 The Authors. Arthritis & Rheumatology is published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Experimental Arthritis Botz, Bálint Bölcskei, Kata Kereskai, László Kovács, Miklós Németh, Tamás Szigeti, Krisztián Horváth, Ildikó Máthé, Domokos Kovács, Noémi Hashimoto, Hitoshi Reglődi, Dóra Szolcsányi, János Pintér, Erika Mócsai, Attila Helyes, Zsuzsanna Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model |
title | Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model |
title_full | Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model |
title_fullStr | Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model |
title_full_unstemmed | Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model |
title_short | Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model |
title_sort | differential regulatory role of pituitary adenylate cyclase–activating polypeptide in the serum-transfer arthritis model |
topic | Experimental Arthritis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320777/ https://www.ncbi.nlm.nih.gov/pubmed/25048575 http://dx.doi.org/10.1002/art.38772 |
work_keys_str_mv | AT botzbalint differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel AT bolcskeikata differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel AT kereskailaszlo differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel AT kovacsmiklos differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel AT nemethtamas differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel AT szigetikrisztian differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel AT horvathildiko differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel AT mathedomokos differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel AT kovacsnoemi differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel AT hashimotohitoshi differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel AT reglodidora differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel AT szolcsanyijanos differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel AT pintererika differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel AT mocsaiattila differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel AT helyeszsuzsanna differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel |